Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 10/2018

01-10-2018 | Brief Report

Phylogenetic analysis of porcine reproductive and respiratory syndrome virus isolates from Northern Ireland

Authors: Natalie Smith, Ultan F. Power, John McKillen

Published in: Archives of Virology | Issue 10/2018

Login to get access

Abstract

To investigate the genetic diversity of porcine reproductive and respiratory syndrome virus (PRRSV) in Northern Ireland, the ORF5 gene from nine field isolates was sequenced and phylogenetically analysed. The results revealed relatively high diversity amongst isolates, with 87.6-92.2% identity between farms at the nucleotide level and 84.1-93.5% identity at the protein level. Phylogenetic analysis confirmed that all nine isolates belonged to the European (type 1) genotype and formed a cluster within the subtype 1 subgroup. This study provides the first report on PRRSV isolate diversity in Northern Ireland.
Literature
1.
2.
Keffaber KK (1989) Reproductive failure of unknown etiology. Am Assoc Swine Pract Newsl 1(2):1–9
3.
Wensvoort G, Terpstra C, Pol JM et al (1991) Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Q 13:121–130CrossRefPubMed
4.
Allende R, Lewis TL, Lu Z et al (1999) North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. Gen Virol 80:307–315CrossRef
5.
Meng X (2000) Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet Microbiol 74:309–329CrossRefPubMed
6.
Fang Y, Schneider P, Zhang WP et al (2007) Diversity and evolution of a newly emerged North American Type 1 porcine arterivirus: analysis of isolates collected between 1999 and 2004. Arch Virol 152:1009–1017CrossRefPubMed
7.
8.
Stadejek T, Stankevicius A, Murtaugh MP, Oleksiewicz MB (2013) Molecular evolution of PRRSV in Europe: current state of play. Vet Microbiol 165:21–28CrossRefPubMed
9.
Brar MS, Shi M, Murtaugh MP, Leung FCC (2015) Evolutionary diversification of type 2 porcine reproductive and respiratory syndrome virus. J Gen Virol 96:1570–1580CrossRefPubMed
10.
Marozin S, Gregory V, Cameron K et al (2002) Antigenic and genetic diversity among swine influenza viruses in Europe. J Gen Virol 83:735–745CrossRefPubMed
11.
Midgley SE, Banyai K, Buesa J et al (2012) Diversity and zoonotic potential of rotaviruses in swine and cattle across Europe. Vet Microbiol 156:238–245CrossRefPubMed
12.
Gunn L, Collins PJ, O’Connell MJ, O’Shea H (2015) Phylogenetic investigation of enteric bovine coronavirus in Ireland reveals partitioning between European and global strains. Ir Vet J 68:31CrossRefPubMedPubMedCentral
13.
Pesente P, Rebonato V, Sandri G et al (2006) Phylogenetic analysis of ORF5 and ORF7 sequences of porcine reproductive and respiratory syndrome virus (PRRSV) from PRRS-positive Italian farms: a showcase for PRRSV epidemiology and its consequences on farm management. Vet Microbiol 114:214–224CrossRefPubMed
14.
Kearse M, Moir R, Wilson A et al (2012) Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647–1649CrossRefPubMedPubMedCentral
15.
Saitou N, Nei M (1987) The neighbour-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed
16.
17.
Wei ZZ, Lin T, Sun LC et al (2012) N-linked glycosylation of GP5 of porcine reproductive and respiratory syndrome virus is critically important for virus replication in vivo. J Virol 86:9941–9951CrossRefPubMedPubMedCentral
18.
Ostrowski M, Galeota JA, Jar AM et al (2002) Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP. J Virol 76:4241–4250CrossRefPubMedPubMedCentral
19.
Wissink EHJ, van Wijk HAR, Kroese MV et al (2003) The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain. J Gen Virol 84:1535–1543CrossRefPubMed
20.
Ropp SL, Wees CEM, Fang Y et al (2004) Characterization of emerging European-like porcine reproductive and respiratory syndrome virus isolates in the United States. J Virol 78:3684–3703CrossRefPubMedPubMedCentral
21.
Meng XJ, Paul PS, Halbur PG, Morozov I (1995) Sequence comparison of open reading frames 2–5 of low and high virulence United States isolates of porcine reproductive and respiratory syndrome virus. J Gen Virol 76:3181–3188CrossRefPubMed
22.
Weiland E, Wieczorek-Krohmer M, Kohl D et al (1999) Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet Microbiol 66:171–186CrossRefPubMed
23.
Frossard J-P, Hughes GJ, Westcott DG et al (2013) Porcine reproductive and respiratory syndrome virus: genetic diversity of recent British isolates. Vet Microbiol 162:507–518CrossRefPubMed
24.
Kvisgaard LK, Hjulsager CK, Kristensen CS et al (2013) Genetic and antigenic characterization of complete genomes of type 1 porcine reproductive and respiratory syndrome viruses (PRRSV) isolated in Denmark over a period of 10 years. Virus Res 178:197–205CrossRefPubMed
25.
Li Y, Wang X, Jiang P et al (2009) Genetic variation analysis of porcine reproductive and respiratory syndrome virus isolated in China from 2002 to 2007 based on ORF5. Vet Microbiol 138:150–155CrossRefPubMed
26.
Stadejek T, Oleksiewicz MB, Scherbakov AV et al (2008) Definition of subtypes in the European genotype of porcine reproductive and respiratory syndrome virus: nucleocapsid characteristics and geographical distribution in Europe. Arch Virol 153:1479–1488CrossRefPubMed
27.
Renukaradhya GJ, Meng X-J, Calvert JG et al (2015) Live porcine reproductive and respiratory syndrome virus vaccines: current status and future direction. Vaccine 33:4069–4080CrossRefPubMed
28.
Charerntantanakul W (2012) Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects. World J Virol 1:23CrossRefPubMedPubMedCentral
29.
Trus I, Bonckaert C, van der Meulen K, Nauwynck HJ (2014) Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain lena. Vaccine 32:2995–3003CrossRefPubMed
30.
Il Kim W, Yoon KJ (2008) Molecular assessment of the role of envelope-associated structural proteins in cross neutralization among different PRRS viruses. Virus Genes 37:380–391CrossRef
31.
Plagemann PGW, Rowland RRR, Faaberg KS (2002) The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch Virol 147:2327–2347CrossRefPubMed
32.
Faaberg KS, Hocker JD, Erdman MM et al (2006) Neutralizing antibody responses of pigs infected with natural GP5 N-glycan mutants of porcine reproductive and respiratory syndrome virus. Viral Immunol 19:294–304CrossRefPubMed
33.
Ansari IH, Kwon B, Osorio FA, Pattnaik AK (2006) Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol 80:3994–4004CrossRefPubMedPubMedCentral
34.
Vu HLX, Kwon B, Yoon K-J et al (2011) Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. J Virol 85:5555–5564CrossRefPubMedPubMedCentral
Metadata
Title
Phylogenetic analysis of porcine reproductive and respiratory syndrome virus isolates from Northern Ireland
Authors
Natalie Smith
Ultan F. Power
John McKillen
Publication date
01-10-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-3886-7

Other articles of this Issue 10/2018

Archives of Virology 10/2018 Go to the issue

Annotated Sequence Record

Genome characterization of the newly identified maize-associated totivirus Anhui

Original Article

Biological characterization of wild-bird-origin avian avulavirus 1 and efficacy of currently applied vaccines against potential infection in commercial poultry

Brief Report

Getah virus epizootic among wild boars in Japan around 2012

Brief Report

Genome polarity of RNA viruses reflects the different evolutionary pressures shaping codon usage

Original Article

Genomic characterization of circoviruses associated with acute gastroenteritis in minks in northeastern China

Original Article

Human herpesvirus type 1 and type 2 disrupt mitochondrial dynamics in human keratinocytes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits